D. E. Shaw & Co »

Monte Rosa Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $372k 50k 7.41
2024-12-31 $487k 70k 6.94
2024-09-30 $97k 18k 5.30
2024-06-30 $88k 23k 3.74
2021-12-31 $492k 24k 20.43
2021-09-30 $1.0M 47k 22.28

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics